Newsroom | 5319 results

Sorted by: Latest

Diabetes
-

American Medical Society for Sports Medicine and OpenEvidence Announce Partnership to Bring AI-Powered Sports Medicine Resources to Clinicians and Patients

MIAMI & LEAWOOD, Kan.--(BUSINESS WIRE)--The American Medical Society for Sports Medicine (AMSSM) and OpenEvidence today announced a partnership that will focus on co-developing AI-powered educational resources on sports medicine for both patients and clinicians. This exclusive collaboration brings the expertise of AMSSM’s sports medicine physicians to OpenEvidence, the leading AI-powered clinical decision support platform, and will build on the AMSSM’s robust foundation of educational materials....
-

Riassunto: NIPPON KINZOKU avvia la produzione in serie di lamiera di acciaio inox ultra-sottile e a larghezza ridotta per aghi da insulina

TOKYO--(BUSINESS WIRE)--NIPPON KINZOKU CO., LTD. (Sede centrale: Minato-ku, Tokyo; Presidente: Yasushi Shimokawa; TOKYO: 5491) è lieta di annunciare l'avvio della produzione in serie della sua "Lamiera di acciaio inox ultra-sottile e a larghezza ridotta" ottimizzata per la saldatura laser di aghi ultra-sottili da insulina. In risposta alla domanda crescente a livello globale, l'azienda ha impostato un sistema per garantire la fornitura stabile di questi materiali di alta qualità. Innovazione te...
-

Samenvatting: NIPPON KINZOKU start met de massaproductie van ultradun en smal roestvrij staal voor insuline-naalden

TOKIO--(BUSINESS WIRE)--NIPPON KINZOKU CO., LTD. (Hoofdkantoor: Minato-ku, Tokio; President: Yasushi Shimokawa; TOKYO: 5491) kondigt verheugd aan dat het "ultradun en smal roestvrij staal" in massa gaat produceren, speciaal geoptimaliseerd voor laserlassen in ultrafijne insuline-naalden. Om aan de groeiende wereldwijde vraag te voldoen, heeft het bedrijf een stabiel bevoorradingssysteem voor deze hoogwaardige materialen opgezet. Technologische innovatie: de overstap naar laserlassen en het opze...
-

NIPPON KINZOKU lance la production en série d’acier inoxydable ultra-fin et de faible largeur destiné aux aiguilles à insuline

TOKYO--(BUSINESS WIRE)--NIPPON KINZOKU CO., LTD. (siège social : Minato-ku, Tokyo ; président : Yasushi Shimokawa ; TOKYO : 5491) a le plaisir d’annoncer le lancement de la production en série de son « acier inoxydable ultra-fin et de faible largeur », optimisé pour le soudage au laser dans la fabrication d’aiguilles à insuline ultra-fines. En réponse à la demande mondiale croissante, la société a mis en place un système d’approvisionnement stable pour ces matériaux de haute qualité. Innovation...
-

Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the Wells Fargo 21st Annual Healthcare Conference in Boston on Wednesday, September 9, 2026, at 2:15 p.m. (Eastern Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About Insulet Corporation: Insu...
-

Resumen: NIPPON KINZOKU pone en marcha la producción en serie de acero inoxidable ultrafino y estrecho para agujas de insulina

TOKIO--(BUSINESS WIRE)--NIPPON KINZOKU CO., LTD. (Sede central: Minato-ku, Tokio; presidente: Yasushi Shimokawa; TOKIO: 5491) tiene el placer de anunciar el inicio de la producción en serie de su «acero inoxidable ultradelgado y de anchura reducida», optimizado para la soldadura por láser en agujas de insulina ultrafinas. En respuesta a la cada vez mayor demanda mundial, la empresa ha establecido un sistema de suministro estable para estos materiales de alta calidad. Innovación tecnológica: tra...
-

NIPPON KINZOKU成功实现胰岛素针头用超薄窄幅不锈钢材料的大规模量产

东京--(BUSINESS WIRE)--(美国商业资讯)-- NIPPON KINZOKU CO., LTD(总部:东京都港区;社长:Yasushi Shimokawa;东京证券交易所代码:5491)欣然宣布,专为超细胰岛素针头激光焊接优化的“超薄窄幅不锈钢”已正式投入量产。为满足全球市场的强劲需求,公司已成功构建起该高品质材料的稳定供应体系。 技术创新:向激光焊接全面转型,构建大批量生产新格局 以往胰岛素针头的制造过程是先使用TIG或等离子焊接技术,将厚度为0.2毫米的基材制成管坯,随后通过反复拉拔和热处理,最终制成超薄规格的针头。 为应对全球激增的市场需求,该行业正加速向激光焊接工艺转型。这一突破性升级不仅大幅提升了焊接速度,更实现了源头控厚——在起始工序即可将基材厚度减薄50%以上(例如降至0.08毫米)。 为满足全球客户对激光焊接专用高品质材料的强劲需求,我们携手行业顶尖制造商展开了深入的研究与测试。如今,我们已成功构建起稳定高效的大规模生产与供应体系,能够持续稳定地提供符合严格质量与性能标准的薄壁、窄幅材料。 主要产品特点与竞争优势 激光焊接对材料质量的要求极其严苛,丝毫不...
-

NIPPON KINZOKU nimmt die Serienproduktion von ultradünnem und schmalem Edelstahl für Insulinnadeln auf

TOKIO--(BUSINESS WIRE)--NIPPON KINZOKU CO., LTD. (Hauptsitz: Minato-ku, Tokio; Präsident: Yasushi Shimokawa; TOKIO: 5491) gibt bekannt, dass das Unternehmen mit der Serienproduktion seines „ultradünnen und schmalen Edelstahls“ begonnen hat, der speziell für das Laserschweißen bei ultrafeinen Insulinnadeln optimiert ist. Als Reaktion auf die weltweit steigende Nachfrage hat das Unternehmen ein stabiles Versorgungssystem für diese hochwertigen Materialien aufgebaut. Technologische Innovation: Ums...
-

NIPPON KINZOKU Establishes Mass Production of Ultra-Thin and Narrow Stainless Steel for Insulin Needles

TOKYO--(BUSINESS WIRE)--NIPPON KINZOKU CO., LTD. (Headquarters: Minato-ku, Tokyo; President: Yasushi Shimokawa; TOKYO: 5491) is pleased to announce the commencement of mass production for its "Ultra-thin and narrow-width stainless steel" optimized for laser welding in ultra-fine insulin needles. In response to growing global demand, the company has established a stable supply system for these high-quality materials. Technological Innovation: Transitioning to Laser Welding and Establishing a New...
-

Hike Medical Raises $22.5M to Modernize the Medical Device Supply Chain from Referral to Device Delivery

SAN FRANCISCO--(BUSINESS WIRE)--Hike Medical, the company automating device-based care from referral to dispense, today announced it has raised $22.5 million in seed and Series A funding to reimagine the entire supply chain for orthotics and prosthetics and durable medical equipment (DME), so more people can access the care that keeps them moving. The round was led by Max Altman at Saga Ventures, with additional participation from Indicator Ventures, Fifth Down Capital, RiverPark Ventures and ot...